Search results
Results from the WOW.Com Content Network
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. [1] It is headquartered in San Diego, California , and led by CEO Kevin Gorman. [ 3 ] Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.
William H. (aka Bill) Rastetter (born 1948), a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics, [4] and of Daré Bioscience, Inc. [5] in San Diego, California.
CEO of Neurocrine Biosciences Inc (30-Year Financial, Insider Trades) Kevin Charles Gorman (insider trades) sold 308,250 shares of NBIX on 01/08/2021 at an average price of $110.22 a share.
This article will reflect on the compensation paid to Kevin Gorman who has served as CEO of Neurocrine Biosciences...
The update presented by Neurocrine included the following information: An End of Phase 2 meeting for NBI-1117568 (NBI-’568, an oral, muscarinic M4 selective agonist) has been completed with the US Food & Drug Administration and Neurocrine reiterated its intentions to begin Phase 3 registrational studies in schizophrenia in 1H 2025.
One failed trial followed by a positive one equals an 11% increase in stock price. Technically Neurocrine Biosciences was up 90% today, but it dropped so much after the first trial, the biotech is ...
Birndorf was also involved in the formation of Gensia (Sicor), and was a founding Director of Neurocrine Biosciences. [5] [6] He was the founder and co-chair of the Coalition for 21st Century Medicine and was founder, Chairman and CEO of Nanogen, Inc. [6]
Tom Athans, co-founder and former CEO of the liberal-progressive Democracy Radio; Mark Bertolini, CEO of Aetna; Howard Birndorf, biotechnology entrepreneur, founding director of Neurocrine Biosciences; Larry Brilliant, executive director of Google.org; Bill Davidson, industrialist, billionaire, majority owner of the Detroit Pistons